Industrial choices for protein production by large-scale cell culture.
about
The Potential for Microalgae as Bioreactors to Produce PharmaceuticalsPutting the Spotlight Back on Plant Suspension CulturesRecent advances in mammalian protein productionGene expression in Mammalian cells and its applicationsDaedalus: a robust, turnkey platform for rapid production of decigram quantities of active recombinant proteins in human cell lines using novel lentiviral vectorsAdvances in Therapeutic Fc Engineering - Modulation of IgG-Associated Effector Functions and Serum Half-lifeAlgae as protein factories: expression of a human antibody and the respective antigen in the diatom Phaeodactylum tricornutumComparison of viable cell concentration estimation methods for a mammalian cell cultivation processOral immunization of haemaggulutinin H5 expressed in plant endoplasmic reticulum with adjuvant saponin protects mice against highly pathogenic avian influenza A virus infection.Membrane-less microfiltration using inertial microfluidics.Very high density of CHO cells in perfusion by ATF or TFF in WAVE bioreactor™. Part I. Effect of the cell density on the process.Computer programs for modeling mammalian cell batch and fed-batch cultures using logistic equations.Reactor engineering in large scale animal cell cultureProduction of a self-activating CBM-factor X fusion protein in a stable transformed Sf9 insect cell line using high cell density perfusion culture.Bioprocess development for the production of mouse-human chimeric anti-epidermal growth factor receptor vIII antibody C12 by suspension culture of recombinant Chinese hamster ovary cells.Effect of amino acid supplementation on titer and glycosylation distribution in hybridoma cell cultures-Systems biology-based interpretation using genome-scale metabolic flux balance model and multivariate data analysis.Characterization of a human monoclonal antibody against Shiga toxin 2 expressed in Chinese hamster ovary cells.Sustained productivity in recombinant Chinese hamster ovary (CHO) cell lines: proteome analysis of the molecular basis for a process-related phenotype.Divergent interactions involving the oxidosqualene cyclase and the steroid-3-ketoreductase in the sterol biosynthetic pathway of mammals and yeasts.Aggravation of cold-induced injury in Vero-B4 cells by RPMI 1640 medium - identification of the responsible medium components.Growth, metabolic activity, and productivity of immobilized and freely suspended CHO cells in perfusion culture.Automated method for the rapid and precise estimation of adherent cell culture characteristics from phase contrast microscopy images.The relationship between mTOR signalling pathway and recombinant antibody productivity in CHO cell lines.Femtosecond laser-induced cell-cell surgical attachment.Production of therapeutic antibodies in plants.Engineering selection stringency on expression vector for the production of recombinant human alpha1-antitrypsin using Chinese Hamster ovary cells.Large-Scale Purification of r28M: A Bispecific scFv Antibody Targeting Human Melanoma Produced in Transgenic Cattle.Strategies for efficient production of heterologous proteins in Escherichia coli.Transgenic plants in the biopharmaceutical market.Evaluation of recombinant human transferrin (DeltaFerrin(TM)) as an iron chelator in serum-free media for mammalian cell culture.The role of recombinant proteins in the development of serum-free media.Proteomic profiling of recombinant cells from large-scale mammalian cell culture processes.Cost-effective production of a vaginal protein microbicide to prevent HIV transmission.The impact of microcarrier culture optimization on the glycosylation profile of a monoclonal antibody.The effects of culture conditions on the glycosylation of secreted human placental alkaline phosphatase produced in Chinese hamster ovary cells.Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single doseMass production of shaped particles through vortex ring freezing.Advances in Mammalian cell line development technologies for recombinant protein production.Glycosylation: impact, control and improvement during therapeutic protein production.Metabolic status of pluripotent cells and exploitation for growth in stirred suspension bioreactors.
P2860
Q26744351-EC7523A7-646D-4537-83F5-AA7AFAB821AEQ26750974-513F82B0-A168-42C2-8EC6-0E032231B97DQ27008285-C34916D7-D3BB-4F9B-94F9-FAB7FB91A48AQ27027017-F53E3B49-0283-4615-9C2D-6CE3FF1579F8Q27673743-298A4D9F-D2B4-4050-9641-0297EE98AFF3Q28079016-FB33E20C-ABDE-46B4-9567-122623CFABADQ28742000-D81EF559-BEEB-4685-9EC7-89FDB768996FQ30318585-C1EDC422-B6C3-4EB0-AD91-CB7DBA7B675DQ30365159-4FBAFE3E-4F85-4143-8380-06191661F646Q30407006-F35E123C-640E-4696-A015-3624C8A1838DQ30450136-CDF36430-DA23-4E53-A1A9-4378A67397CAQ30451382-632F6E78-BDD7-4A90-A525-697F9C4A5BCCQ30462037-11FB83CC-C37D-4055-A8AD-F87EC56A21ABQ30462045-86F838C0-FECB-4B11-9658-3A69DD07541EQ30467990-2B5499C0-21E0-4557-9DB1-FF1F05017B9AQ31117108-4B4EED40-B3D7-495F-B281-F1484E085034Q33883354-D785072B-D10A-4F60-ABE2-EFBD84EE6119Q33969027-82CDEAB6-6C43-4A26-A730-C19DCBFB35C4Q34158659-6B1F5215-E1A5-4E86-980D-59728D4481DBQ34437136-D0AA1EBE-DC0A-4743-9BF7-E1568712B13CQ34735782-E7C542AD-C030-4802-B736-D1DBE2A217C6Q34987570-CA4F6F5E-4CA9-4870-ADBF-86D918DE5392Q35095832-9C09E375-3D59-468D-9C40-C6654FBB12A8Q35097042-ABBE49B4-D848-4E91-BAE5-7D0DABBB12EAQ35547282-C810B874-E4BD-432E-B4F4-EBE96B0B6BF8Q35649129-3043CA79-DEFD-412F-B825-E43B133852F1Q35808466-3427053B-DC9E-46BB-B01D-D2F4C80C509AQ36001048-92C5032F-E0BE-455B-BF76-FE57476C9C87Q36066053-0E67938F-4EBC-4C28-A973-727EB634BAECQ36254614-0051D4B7-641D-418A-A917-28672FB69963Q36331919-688931C4-2214-4549-8BF8-995A9B3059CFQ36495983-8A73F570-E2CC-4BE8-AFD9-2003DCCA0C59Q36499053-58EE8781-C954-4AD1-B10A-059E3902CAF8Q36670313-7AEF2208-4238-4D8D-AC94-6F56A8BF3768Q37106821-B84AFED7-1B3C-44B7-8795-EE52ADCD7E92Q37126611-B09AD27D-AF89-4CFB-B2F8-0ACB95B837C7Q37157265-7737579C-7912-46B6-9F02-85DB5F06A642Q37280293-4D09AA51-C0A1-4F01-A0E7-59A91AD4FC42Q38126913-123F27E8-6152-4F96-BCBC-27FFA3D8BF22Q38191005-12F4E3FB-EE02-416C-B1F2-47158B60C253
P2860
Industrial choices for protein production by large-scale cell culture.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Industrial choices for protein production by large-scale cell culture.
@ast
Industrial choices for protein production by large-scale cell culture.
@en
Industrial choices for protein production by large-scale cell culture.
@nl
type
label
Industrial choices for protein production by large-scale cell culture.
@ast
Industrial choices for protein production by large-scale cell culture.
@en
Industrial choices for protein production by large-scale cell culture.
@nl
prefLabel
Industrial choices for protein production by large-scale cell culture.
@ast
Industrial choices for protein production by large-scale cell culture.
@en
Industrial choices for protein production by large-scale cell culture.
@nl
P1476
Industrial choices for protein production by large-scale cell culture.
@en
P2093
P304
P356
10.1016/S0958-1669(00)00197-X
P577
2001-04-01T00:00:00Z